MARKET

CYBN

CYBN

Cybin Inc
AMEX
5.95
+0.07
+1.18%
Opening 09:30 12/05 EST
OPEN
6.00
PREV CLOSE
5.95
HIGH
6.00
LOW
6.00
VOLUME
3.02K
TURNOVER
14.10K
52 WEEK HIGH
11.08
52 WEEK LOW
4.810
MARKET CAP
296.87M
P/E (TTM)
-1.8475
1D
5D
1M
3M
1Y
5Y
1D
Psychedelic: Clearmind reports CMND-100 dosing at Hadassah Medical Center
TipRanks · 23h ago
Guggenheim Maintains Buy on Cybin, Raises Price Target to $48
Benzinga · 1d ago
Cybin price target raised to $48 from $39 at Guggenheim
TipRanks · 2d ago
Weekly Report: what happened at CYBN last week (1124-1128)?
Weekly Report · 4d ago
Cybin Secures $175 Million in Direct Offering to Advance Clinical Programs
TipRanks · 11/26 17:18
Weekly Report: what happened at CYBN last week (1117-1121)?
Weekly Report · 11/24 09:55
Psychedelic: Clearmind reports results from first cohort in AUD trial
TipRanks · 11/20 17:05
Canaccord Genuity Maintains Buy on Cybin, Lowers Price Target to $45
Benzinga · 11/20 16:02
More
About CYBN
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N, N-dimethyltryptamine (DMT) and dDMT programs create a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II.CYB005 is in Preclinical stage. It has an intellectual property portfolio in the psychedelic drug development sector with over 80 patents granted and over 230 patent applications pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.

Webull offers Cybin Inc stock information, including AMEX: CYBN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYBN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CYBN stock methods without spending real money on the virtual paper trading platform.